Literature DB >> 10888390

Stress perfusion/metabolism imaging: a pilot study for a potential new approach to the diagnosis of coronary disease in women.

B L Abramson1, T D Ruddy, R A deKemp, L A Laramee, J F Marquis, R S Beanlands.   

Abstract

BACKGROUND: The diagnosis of coronary artery disease (CAD) in women continues to be a challenge. F-18 deoxyglucose (FDG) positron emission tomography (PET) has been used for detection of myocardial ischemia at rest. Little has been reported about FDG stress imaging. The aim of this pilot study was to assess stress FDG PET imaging for defining CAD in a group of women referred for chest pain.
METHODS: Stress FDG imaging was performed in 19 women (mean age 59 +/- 10 years). All had abnormal stress testing before entering the study. FDG and 2-methoxy-2-methylpropyl isonitrile were injected at peak stress (treadmill n = 8, dipyridamole n = 11) followed by PET and single photon emission computed tomography image acquisitions. Myocardial ischemia was defined by regions that demonstrated both a defect on perfusion imaging and increased FDG uptake relative to uptake in normal perfusion zones. Defect/normal zone FDG ratios were also determined. Coronary angiography was performed on all patients.
RESULTS: Average, or mean, body mass index was high at 29.2 +/- 5 kg/m2. Nine of 19 patients had significant CAD. Eight of 9 with CAD had FDG-defined ischemia. Nine of the 10 without CAD had negative FDG images (sensitivity 89%, specificity 90%). The average defect/normal zone FDG ratio was greater in patients with CAD than in those without (2.4 +/- 1.9 vs 0.9 +/- 0.4, P < .05).
CONCLUSIONS: Regional FDG uptake in areas of perfusion defects with stress increased in this group with CAD. These pilot data suggest that stress FDG PET may be diagnostically helpful in obese female patients. This novel approach may complement current methods of CAD detection in women and warrants further study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888390     DOI: 10.1016/s1071-3581(00)70008-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  37 in total

1.  Clinical competence in exercise testing. A statement for physicians from the ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology.

Authors:  R C Schlant; G C Friesinger; J J Leonard
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

2.  Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals.

Authors:  B M Gallagher; A Ansari; H Atkins; V Casella; D R Christman; J S Fowler; T Ido; R R MacGregor; P Som; C N Wan; A P Wolf; D E Kuhl; M Reivich
Journal:  J Nucl Med       Date:  1977-10       Impact factor: 10.057

3.  Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.

Authors:  R W Burt; O W Perkins; B E Oppenheim; D S Schauwecker; L Stein; H N Wellman; R M Witt
Journal:  J Nucl Med       Date:  1995-02       Impact factor: 10.057

4.  Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing.

Authors:  R Hachamovitch; D S Berman; H Kiat; C N Bairey; I Cohen; A Cabico; J Friedman; G Germano; K F Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1996-07       Impact factor: 24.094

5.  Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease.

Authors:  R E Patterson; R L Eisner; S F Horowitz
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

6.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

7.  Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.

Authors:  R S Beanlands; P J Hendry; R G Masters; R A deKemp; K Woodend; T D Ruddy
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

8.  Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.

Authors:  P Camici; L I Araujo; T Spinks; A A Lammertsma; J C Kaski; M J Shea; A P Selwyn; T Jones; A Maseri
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

Review 9.  Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography.

Authors:  P Camici; E Ferrannini; L H Opie
Journal:  Prog Cardiovasc Dis       Date:  1989 Nov-Dec       Impact factor: 8.194

10.  Does it matter how coronary projections are combined to assess restenosis following PTCA?

Authors:  B C Morton; J B Gill; R S Roberts; B G Larocque; L A Jozwiak; J A Cairns
Journal:  Int J Card Imaging       Date:  1995-09
View more
  10 in total

1.  Exercise-induced myocardial ischemia: can this be imaged with F-18-fluorodeoxyglucose?

Authors:  D Jain; P H McNulty
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

2.  F-18 fluorodeoxyglucose imaging in myocardial ischemia: beyond myocardial viability.

Authors:  J A Arrighi
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

Review 3.  Hypersensitivity reactions to corticosteroids.

Authors:  Rani R Vatti; Fatima Ali; Suzanne Teuber; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

4.  Comparison of Tc-99m tetrofosmin myocardial perfusion scintigraphy and exercise F18-FDG imaging in detection of myocardial ischemia in patients with coronary artery disease.

Authors:  Sasikumar Arun; Bhagwant Rai Mittal; Anish Bhattacharya; Manoj Kumar Rohit
Journal:  J Nucl Cardiol       Date:  2014-08-15       Impact factor: 5.952

5.  Direct myocardial ischemia imaging with exercise ¹⁸FDG.

Authors:  Diwakar Jain; Zuo-Xiang He
Journal:  J Nucl Cardiol       Date:  2015-02       Impact factor: 5.952

Review 6.  Exercise (18)FDG imaging for the detection of CAD: What are the clinical hurdles?

Authors:  Diwakar Jain; Zuo-Xiang He; Afshin Ghanbarinia
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

7.  Direct imaging of myocardial ischemia: a potential new paradigm in nuclear cardiovascular imaging.

Authors:  Diwakar Jain; Zuo-Xiang He
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

Review 8.  Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.

Authors:  Caitlund Q Davidson; Christopher P Phenix; T C Tai; Neelam Khaper; Simon J Lees
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05

9.  Dual-time-point myocardial 18F-FDG imaging in the detection of coronary artery disease.

Authors:  Ke-Fei Dou; Xiao-Jin Gao; Bo-Qia Xie; Yan Li; Zuo-Xiang He; Min-Fu Yang
Journal:  BMC Cardiovasc Disord       Date:  2017-05-10       Impact factor: 2.298

10.  Stress Classification Using Brain Signals Based on LSTM Network.

Authors:  Nishtha Phutela; Devanjali Relan; Goldie Gabrani; Ponnurangam Kumaraguru; Mesay Samuel
Journal:  Comput Intell Neurosci       Date:  2022-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.